MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1
about
MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expressionmiR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1.Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair.The role of membrane transporters in ovarian cancer chemoresistance and prognosis.miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview.Pharmacoepigenetics: an element of personalized therapy?MicroRNAs in gynecological cancers: Small molecules with big implications.MicroRNA-mediated drug resistance in ovarian cancer.Weakening Impact of Excessive Human Serum Albumin (eHSA) on Cisplatin and Etoposide Anticancer Effect in C57BL/6 Mice with Tumor and in Human NSCLC A549 CellsMolecular mechanisms of drug resistance in ovarian cancer.Inhibition of miR-186-5p contributes to high glucose-induced injury in AC16 cardiomyocytes.MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1.Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1.
P2860
Q30244282-43107116-C89A-4828-A3D8-4759C8CDA132Q37584834-114AE631-DC08-45E5-8621-0FCDDE290852Q37694872-960CB1E7-FBF9-4FE7-916B-A346E62E5A6DQ37736667-50562482-E803-40D7-96AD-B2E59BA7E77AQ38683064-4975C90C-AB36-40D0-8707-B82A10B35130Q38740398-8F3801B7-CCB8-4804-99E8-AF5DABC8670CQ38908841-7626F3CD-B2AE-4A9F-913A-8B9C7849DF01Q39012550-94E30186-F7B1-4772-BA33-9275901A70B1Q39333266-C7A12634-2C86-4EC2-968D-EE5C637AF79BQ39382756-045E432A-0B29-48BD-A437-E57E31E0969BQ41807830-B882D2E9-11A6-4585-92F2-335E6B3ACB79Q48274587-56809D45-9DD7-46CC-9A32-66D5EEDFFC25Q49335803-0C0F6454-A16C-4F4B-B04C-9C144113FE4BQ50071627-631E17C7-5304-487C-A469-8FAF44FFA50AQ52645998-9F7D5D6C-A3D6-41CA-B192-AC5CFE785CD3
P2860
MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
MicroRNA-186 induces sensitivi ...... d cisplatin by targeting ABCB1
@ast
MicroRNA-186 induces sensitivi ...... d cisplatin by targeting ABCB1
@en
type
label
MicroRNA-186 induces sensitivi ...... d cisplatin by targeting ABCB1
@ast
MicroRNA-186 induces sensitivi ...... d cisplatin by targeting ABCB1
@en
prefLabel
MicroRNA-186 induces sensitivi ...... d cisplatin by targeting ABCB1
@ast
MicroRNA-186 induces sensitivi ...... d cisplatin by targeting ABCB1
@en
P2093
P2860
P1476
MicroRNA-186 induces sensitivi ...... d cisplatin by targeting ABCB1
@en
P2093
Bo-Liang Liu
Jin-Wen Jiao
Kai-Xuan Sun
P2860
P2888
P356
10.1186/S13048-015-0207-6
P577
2015-12-02T00:00:00Z
P5875
P6179
1028025921